ImmunologybioRxivPreprint
TMEM33 deletion potentiates anti-tumor CD8+ T cell immunity
Matthew P. Jackson, T. Zhao, Gusztav Milotay…·Eileen E. Parkes
This study shows TMEM33 limits progenitor-exhausted CD8+ T cells, enhances anti-tumor responses, and correlates with improved survival in melanoma patients.
DOI 10.64898/2026.01.01.697288